About Michael Bowen
Michael Bowen is a chief financial officer at Vesicor Therapeutics.
Michael Bowen reports to the SEC as an officer of 1 public company: Nutex Health (NUTX).
Michael Bowen first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Bowen in the role, so the role may have started earlier or lasted longer.
NI
Nutex Health Inc.
Retired CFO
2022 · Public company (NUTX)
Key Colleagues at Startups
The people Michael Bowen works with at each company, as listed on that company's latest Form D.
Vesicor Therapeutics, Inc. · Form D, May 14, 2025
WH
Warren Jr. Hosseinion
Executive officer
OL
Oded Levy
Director
LF
Luo Feng
Executive officer and director
WH
Warren Hosseinion
Director